Abstract: A series of chiral compounds were designed and synthesized as novel multidrug resistance (MDR) modulators on the basis of tetrahydroisoquinolines to reverse cancerous MDR on K562 cells and K562/DOX cells by using the MTT assay. The treatment of K562/DOX cells with 9e, 10a and 10e led to increased intracellular accumulation and decreased efflux of doxorubicin. The pharmacological effects of these tetrahydroisoquinolines on P-glycoprotein (P-gp) mediated MDR were much stronger than that of positive control drug verapamil.
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INTRODUCTION
Multidrug Resistance (MDR) has been considered as one of the major obstacles for successful chemotherapy in patients with cancers. It is a type of acquired drug resistance of tumor cells to various kinds of chemotherapic agents with different structural and mechanical features. Although the molecular mechanisms leading to MDR include the activation of transport and detoxification systems, enhancement of target repair activities, alterations of drug targets, and disregulation of cells death pathways, the over-expression of a variety of proteins that act as ATP-dependent extrusion pumps such as P-gp has always been thought to be concerned with this phenomenon [1] . The efflux function of Pgp can be responsible for the decrease of drug concentrations in tumor cells, resulting in chemotherapeutic failure [2] . Much work to overcome MDR by influencing transporter expressions via signal transduction pathways or by direct transcriptional control has been done and proven unsuccessful in clinical trials. Verapamil [3] was the first and also the most typical P-gp inhibitor. Tsuruo et al. demonstrated that this calcium channel blocker possessed potent activity on reversal of MDR through inhibition of P-gp [4, 5] . Furthermore, a number of other structurally unrelated compounds such as cyclosporin [3] , phenothiazines, antimalarials have also been demonstrated to be effective P-gp inhibitors. However, many of these compounds could not enter into clinical trails due to their unacceptable toxicities for antitumor treatment or nonspecific and weak inhibitory effect on P-gp. Therefore, many efforts should be devoted to identifying new kinds of P-gp inhibitors with higher selectivity and stronger potency.
Recently, the natural alkaloid tetrandrine [6] was found to inhibit P-gp, attributing this activity to its bisbenzylisoquinoline scaffold. It has been shown that isoquinoline alkaloid could effectively reverse MDR with low side effects [7, 8] . Based on these observations, many tetrahydroisoquinoline derivatives were designed and synthesized for the search of novel calcium channel blockers by simplifying and optimizing bisbenzylisoquinoline alkaloid tetrandrine. Studies on these novel derivatives have shown that 6,7-dimethoxy-1-(3,4-dimethoxy)benzyl-2-(N-n-octyl-N'-cyano)guanyl-1,2,3, 4-tetrahydroisoquinoline is more active than verapamil and dose not have cardiovascular activity [9] . These derivatives are racemates and the question of the streroselectivity of transport mediated by P-gp is of relevance [10] . Additionally, according to some fundamental biochemical studies, it could be speculated that P-gp has multiple substrate-binding sites and an allosteric regulatory site, although the number of sites, their chemical selectivities, and their mutual relationships remain uncentain [11] . Based on these facts, we report a new kind of tetrahydroisoquinoline derivatives containing N-substituted aminoacetyl groups may further enhance its bioactivity. In an attempt to develop novel and more potent P-gp inhibitors, a number of tetrahydroisoquinoline derivatives were designed and synthesized and their structureactivity relationship against P-gp activity was explored. To investigate the influence of stereoselectivity on pharmacological properties, individual enantiomers of tetrahydropapaverine were prepared in comparison with racemate at low or high substrate concentration. The MDR reversal activities of the tetrahydroisoquinoline analogues in vitro against K562/DOX cell line [12] , a human leukemia cell line, were evaluated by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) colorimetric assay [13] .
SYNTHESIS
Homoveratrylamine 1 and phenylacetic acid 2a-c (3,4-dimethoxyphenylacetic acid, 3,4-diethoxyphenylacetic acid, 4-hydroxylphenylacetic acid) provided phenylacetamides 3a-c (Scheme (1)). The next conversion from 3c to 3d was performed by applying tetrabutylammonium bromide (TBAB) [14] , a liquid-liquid phase transfer catalyst (LL-PTC), which catalyzed the reaction between benzyl chloride and phenol 3c to afford 3d in an alkaline solution of NaOH and organic solvents (Scheme (2)). The first step of the reaction is the yielding of sodium phenoxide (PhO Na + ) by reacting phenol with sodium hydroxide in the aqueous phase. Compound 3d was provided by treatment of phenoxide with 3c in the organic solvent. The synthesis of 3,4-dihydroisoquinoline analogues 4a-c was achieved from the corresponding phenylacetamides 3a, 3b and 3d in the presence of the dehydrating agent phosphory chloride in toluene (Scheme (3)). The imine double bond in compounds 4a-c provided a prochiral environment for the enantio-selective formation. Imines 4a-c were subsequently reduced by potassium tetrahydroborate with triethylamine in refluxing methanol for 24 h, affording tetrahydroisoquinolines 5a-c in over 80% yields.
The carbon atom on the tetrahydroisoquinoline scaffold of 5a-c, as a stereogenic center, has a particular optical isomeric configuration leading to two optically active forms: (R) and (S). In order to investigate the chiral effects on pharmacological properties, two optical isomers of tetrahydropapaverine 5a were obtained via chemical resolution using N-acetyl-L-leucine as a chiral resolution reagent [15] .
The chiral resolution reagent 6 was prepared by acetylation of commercially available L-leucine with acetic anhydride, followed by crystallization of the crude product in water solvent (Scheme (4)). The chemical resolution with racemate 5a and N-acetyl-L-leucine can produce their diastereoisomer salts with optical active (R)-or (S)-tetrahydropapaverine Nacetyl-L-leucinate, respectively, which were further purificated by recrystallization in acetone. The optical active (R)-or (S)-tetrahydropapaverine N-acetyl-L-leucinate was alkalinized with aqueous ammonia to obtain the individual enantiomer (R)-or (S)-6a in a good yield and an excellent stereoselectivity (> 99% as indicated by chiral high performance liquid chromatography).
The key intermediates 7a-c, (R)-7a, (S)-7a
were prepared by the reaction between the corresponding tetrahydroisoquinolines 5a-c, (R)-5a, (S)-5a and chloroacetyl chloride. Potassium carbonate in the reaction played a role in absorbing the liberating HCl gas and neutralizing the whole reaction system. The final racemates 8a-b, 9a-e, 10a-e were obtained from the alkylation of corresponding amines (diethylamine, morpholine, piperazine, pyrrole, N-methylpiperazine) .
Six chiral derivatives of tetrahydropapaverine (R)-8a-d, (S)-8a-b
were given by using the same procedure (Scheme (5) 
BIOLOGICAL TESTS
The cytotoxicity [17] and MDR reversal activities [18] of tetrahydroisoquinoline derivatives and their chiral enantiomers were evaluated by the MTT colorimetric assay [13] with the required concentration. The MDR reversal activities of all the target compounds in vitro were listed in Table 1 . When tested in combination with doxorubicin against the K562/DOX cell line at 10 μM, compounds 9e, 10a and 10e exhibited a well-defined trend in MDR reversal activities. Compared to the other N-substituted acetyl position tetrahy-droisoquinolines, compounds with morpholine (10a) or diethylamine (10e) group exhibit were more potent. The compound 9e, also containing diethylamine group, showed almost the same MDR activity as compound 10e. Considering their different chemical structures, these results indicated that morpholine and diethylamine groups displayed an essential factor in the interaction of compounds with P-gp by providing an appropriate hydrophilicity which was required by P-gp substrates for better binding with the amine side-chain. Furthermore, in comparison to compounds with 3-and 4-methoxy groups, the substitution of 3-and 4-ethoxy group or O-CH 2 -phenyl on the 1-benzyl position played a significant part to increase the activity of MDR. The optical tetrahydroisoquinolines 8a, 8b and their racemates (R)-8a-d, (S)-8a-b, at the concentrations tested, displayed minimal modulatory activity.
Hence, the conclusion could be obtained that the phenoxy and amino-acetyl substituent on tetrahydroisoquinoline can enhance its interaction with P-gp and prevent its substrate efflux activity. But the chirality of this series of compounds was independent of MDR modulation activity. The mode of interaction with these modified tetrahydroisoquinolines appears to be quite different, given the broad differences noted in cytotoxicity, inhibition ratio, half inhibiting concentration and reversal fold. In summary, the N-substituted tetrahydroisoquinolines are considered as very promising modulators of P-gp function and warrant further exploration.
CONCLUSION
In this work, BNR was applied to the synthesis of several tetrahydroisoquinoline derivatives. These compounds bearing a quaternary carbon atom were evaluated for their MDR reversal activities against K562/DOX cell line in vitro. The results showed that compounds 9e, 10a, and 10e exhibited higher MDR reversal activities than verapamil. These compounds all belonged to racemate, and among all the tetrahydropapaverine derivatives, both enantiomers and racemates had the low MDR reversal activities. Further biological evaluation, structure-activity relationship and mechanistic studies on this new class of compounds are currently in progress. The drug sensitive human leukemia cell line, K562, and its drugresistant variant, K562/DOX, were were cultured in RPMI-1640 medium supplemented with 10% FBS at 37 °C in a humidified atmosphere of 5% CO2 incubator. The K562/DOX cells were grown in the presence of 1 μg/mL doxorubicin for at least 14 d before used. [13] Mosmann, T. Rapid colorimetric assay for cellular growth and survival: appliation to proliferation and cytotoxicity. J. Immunol. Methods, 1983, 65(1-2) , 55-63. [14] Yadav, G.D.; Ceasar, J.L. Novelties of cyanide displacement reaction in ibuprofen amide process by phase transfer catalysis: Solidliquid versus solid-liquid (omega)-liquid systems. J. Mol. Catal. A Chem., 2006, 260(1-2), 202-209. [15] Hill, D.A.; Turner, G.L. Neuromuscular blocking agents. US Patent 5453510, 1995. [16] The tested compounds were purified by silica gel column chromatography, eluting with a mixture of ethyl acetate and petroleum ether. The compounds were characterized by elemental analysis with satisfactory results. Their 1 H NMR and MS spectra were in agreement with the assigned structures. Physical and spectral properties of compounds 8a-b, 9a-e, 10a-e, (R)-8a-d, (S)-8a-b are given. 1 H NMR data were obtained at 300MHz, using CDCl3 as solvent. 8a: mp: 156-160 °C. 5H), 5.67, 5.17, 4.75 (m, 1H, CH), 3.84 (s, 6H, 2 OCH3), 3.82 (s, 6H, 2 OCH3), 3.72 (s, 2H, CH2CO), 3.65 (m, 4H, O(CH2) 2), 3.47 (m, 2H, PhCH2CH2), 3.21-2.51 (m, 4H, PhCH2, CHCH2), 2.40 (m, 4H, N(CH2)2). MS (ESI, m/z): 471.3 ([M+H] + , base peak). Anal. calcd for C26H34N2O6: C, 66.36; H, 7.28; N, 5.95. Found: C, 66.56; H, 7.30; N, 5.97 C26H35N3O5: C, 66.50; H, 7.51; N, 8.95. Found: C, 66.70; H, 7.53; N, 8.98 + , base peak). Anal. calcd for C26H35N3O5: C, 66.50; H, 7.51; N, 8.95. Found: C, 66.70; H, 7.53; N, 8.98 
